Content uploaded by Carolin Solomi
Author content
All content in this area was uploaded by Carolin Solomi on Jan 17, 2021
Content may be subject to copyright.
Content uploaded by Vijay Anand Ismavel
Author content
All content in this area was uploaded by Vijay Anand Ismavel on Jul 07, 2020
Content may be subject to copyright.
Open Peer Review
METHODARTICLE
Maternal and perinatal Health Research Collaboration, India
(MaatHRI): methodology for establishing a hospital-based
research platform in a low and middle income country setting
[version 1; peer review: awaiting peer review]
ManishaNair , BabulBezbaruah , AmritKrishnaBora , KrishnaramBora ,
ShakuntalaChhabra , SaswatiS.Choudhury , ArupChoudhury , DipikaDeka ,
GitanjaliDeka , VijayAnandIsmavel , SwapnaD.Kakoty , RoshineM.Koshy ,
PramodKumar , PranabikaMahanta , RobinMedhi , PranoyNath ,
AnjaliRani , IndraniRoy , UshaSarma , CarolinSolomiV ,
RatnaKantaTalukdar , FarzanaZahir , MichaelHill , NimmiKansal ,
ReenaNakra , ColinBaigent , MarianKnight , JennyJ.Kurinczuk1
NationalPerinatalEpidemiologyUnit,NuffieldDepartmentofPopulationHealth,UniversityofOxford,Headington,Oxford,Oxfordshire,OX3
7LF,UK
SilcharMedicalCollegeandHospital(SMCH),GhungoorRoad,Masimpur,Assam,788014,India
MahendraMohanChoudhuryHospital,Panbazar,Guwahati,Assam,781001,India
NagaonBhogeswariPhukananiCivilHospital,Haibargaon,Daccapatty,Nagaon,Assam,782001,India
MahatmaGandhiInstituteofMedicalSciences,Sevagram,Maharashtra,442102,India
GauhatiMedicalCollegeandHospital(GMCH),Bhangagarh,Guwahati,Assam,781032,India
DhubriCivilHospital,Jhagrarpar,Dhubri,Assam,783324,India
SrimantaSankaradevaUniversityofHealthSciences,NarkashurHilltop,Bhangagarh,Assam,781032,India
TezpurMedicalCollege,NH15,Tezpur,Assam,784153,India
MakundaChristianLeprosyandGeneralHospital,Bazaricherra,Karimganj,Assam,788727,India
FakhruddinAliAhmedMedicalCollegeandHospital(FAAMCH),Barpeta-Hospital-JaniaRd,JotiGaon,Assam,781301,India
JorhatMedicalCollegeandHospital,KushalKonwarPath,Barbheta,Jorhat,Assam,785001,India
InstituteofMedicalSciences,BanarasHinduUniversity,AurobindoColony,BanarasHinduUniversityCampus,Varanasi,UttarPradesh,
221005,India
NazarethHospital,ArbuthnotRd,Nongkynrih,Laitumkhrah,Shillong,Meghalaya,793003,India
AssamMedicalCollege(AMC),Barbari,Dibrugarh,Assam,786002,India
NDPHWolfsonLaboratories,NuffieldDepartmentofPopulationHealth,UniversityofOxford,OldRoadCampus,Headington,Oxford,
Oxfordshire,OX37LF,UK
NationalReferenceLaboratory,DrLalPathLabs,B7Rd,BlockE,Sector18,Rohini,NewDelhi,Delhi,110085,India
MRCPopulationHealthResearchUnit,NuffieldDepartmentofPopulationHealth,UniversityofOxford,OldRoadCampus,Headington,
Oxfordshire,OX37LF,UK
Equalcontributors
Abstract
1 2* 3* 4*
5* 6* 7* 8*
9* 10* 11* 10*
5* 12* 11* 2*
13* 14* 9* 10*
6* 15* 16 17
17 18 1 1
1
2
3
4
5
6
7
8
9
10
11
12
13
14
15
16
17
18
*
Reviewer Status AWAITING PEER REVIEW
07Jul2020, :683First published: 9
https://doi.org/10.12688/f1000research.24923.1
07Jul2020, :683Latest published: 9
https://doi.org/10.12688/f1000research.24923.1
v1
Page 1 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
Anyreportsandresponsesorcommentsonthe
articlecanbefoundattheendofthearticle.
Abstract
MaternalandperinatalHealthResearchcollaboration,IndiaBackground:
(MaatHRI)isaresearchplatformthataimstoimproveevidence-based
pregnancycareandoutcomesformothersandbabiesinIndia,acountry
withthesecondhighestburdenofmaternalandperinataldeaths.The
objectiveofthispaperistodescribethemethodsusedtoestablishand
standardisetheplatformandtheresultsoftheprocess.
MaatHRIisahospital-basedcollaborativeresearchplatform.ItisMethods:
adaptedfromtheUKObstetricSurveillanceSystem(UKOSS)andbuilton
apilotmodel(IndOSS-Assam),whichhasbeenextensivelystandardised
usingthefollowingmethods:(i)establishinganetworkofhospitals;(ii)
settingupasecuresystemfordatacollection,storageandtransfer;(iii)
developingastandardisedlaboratoryinfrastructure;and(iv)developing
andimplementingregulatorysystems.
MaatHRIwasestablishedinSeptember2018.FourteenhospitalsResults:
participateacrossfourstatesinIndia–Assam,Meghalaya,UttarPradesh
andMaharashtra.Theresearchteamincludes20nurses,aproject
manager,16obstetricians,twopathologists,apublichealthspecialist,a
generalphysicianandapaediatrician.MaatHRIhasadvanced
standardisationofdataandlaboratoryparameters,real-timemonitoringof
dataandparticipantsafety,andsecuretransferofdata.Fourobservational
epidemiologicalstudiesarepresentlybeingundertakenthroughthe
platform.MaatHRIhasenabledbi-directionalcapacitybuilding.Itis
overseenbyasteeringcommitteeandadatasafetyandmonitoringboard,
aprocessthatisnotnormallyused,butwasfoundtobehighlyeffectivein
ensuringdatasafetyandequitablepartnershipsinthecontextoflowand
middleincomecountries(LMICs).
MaatHRIisthefirstprototypeofUKOSSandothersimilarConclusion:
platformsinaLMICsetting.Themodelisbuiltonexistingmethodsbut
appliesnewstandardisationprocessestodevelopacollaborativeresearch
platformthatcanbereplicatedinotherLMICs.
Keywords
Researchplatform,researchmodel,epidemiology,low-and-middleincome
country,India,maternalhealth,perinatalhealth
Page 2 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
ManishaNair( )Corresponding author: manisha.nair@npeu.ox.ac.uk
:Conceptualization,DataCuration,FormalAnalysis,FundingAcquisition,Investigation,Methodology,ProjectAdministration,Author roles: Nair M
Resources,Software,Supervision,Validation,Visualization,Writing–OriginalDraftPreparation,Writing–Review&Editing; :Bezbaruah B
Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,Bora AK
ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Bora K
Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Chhabra S
Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Choudhury SS Choudhury A
Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectDeka D
Administration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Deka G
Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Ismavel VA
Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Kakoty SD Koshy RM
Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,Kumar P
ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Mahanta P
Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Medhi R
Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Nath P Rani A
Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectRoy I
Administration,Resources,Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Sarma U
Validation,Writing–Review&Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&V CS
Editing; :Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Talukdar RK Zahir F
Investigation,Methodology,ProjectAdministration,Resources,Validation,Writing–Review&Editing; :Methodology,Validation,Writing–Hill M
Review&Editing; :Methodology,Resources,Validation,Writing–Review&Editing; :Methodology,Resources,Validation,Kansal N Nakra R
Writing–Review&Editing; :Methodology,Validation,Writing–Review&Editing; :Methodology,Validation,Writing–ReviewBaigent C Knight M
&Editing; :Methodology,Validation,Writing–Review&EditingKurinczuk JJ
Nocompetinginterestsweredisclosed.Competing interests:
TheMaatHRIplatformisfundedbyaMedicalResearchCouncilCareerDevelopmentAwardtoMN(Ref:MR/P022030/1).Grant information:
The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.
©2020NairM .Thisisanopenaccessarticledistributedunderthetermsofthe ,whichCopyright: et al CreativeCommonsAttributionLicense
permitsunrestricteduse,distribution,andreproductioninanymedium,providedtheoriginalworkisproperlycited.
NairM,BezbaruahB,BoraAK How to cite this article: et al. Maternal and perinatal Health Research Collaboration, India (MaatHRI):
methodology for establishing a hospital-based research platform in a low and middle income country setting [version 1; peer review:
F1000Research2020, :683awaiting peer review] 9 https://doi.org/10.12688/f1000research.24923.1
07Jul2020, :683First published: 9 https://doi.org/10.12688/f1000research.24923.1
Page 3 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
Introduction
Maternal health is a global priority due to the large number
of women becoming pregnant every year, an estimated
211 million1, and because of the growing disparity in mater-
nal deaths across countries2,3. India has the second high-
est number of maternal deaths with ~45,000 deaths yearly2.
The rate is much higher for some states, such as Assam in
the Northeast of India. Assam has nearly half the popula-
tion of the UK, and 6 women die every day as a result of preg-
nancy and childbirth complications4 compared with around
one per week in the UK5. In addition, each year an estimated
5 million pregnant women in India experience a life-threatening
complication. To improve care and outcomes, India needs
large and robust studies to investigate the risk factors, manage-
ment and outcomes of pregnancy complications and to find
out why disease severity varies from state to state.
In a pilot project (called IndOSS-Assam) we demonstrated
the feasibility of setting up a collaborative platform for mater-
nal and perinatal health research jointly undertaken by Indian
clinical collaborators and researchers at the University of
Oxford6,7. This was modelled on the UK Obstetric Surveillance
System (UKOSS)8 and showed that a hospital-based platform
can be used to conduct large epidemiological studies and rou-
tine surveys to investigate pregnancy complications and man-
agement, and establish incidence and outcomes. UKOSS
through its work over the past decade has contributed signifi-
cantly to improving the safety and quality of care for pregnant
women8. It has inspired several high-income countries to estab-
lish obstetric surveillance and research systems, which are being
used to conduct national and multi-national studies to gener-
ate evidence to improve pregnancy care. However, there is
no such system in low-and-middle income countries (LMICs)
where more than 94% of all maternal deaths occur.
Our pilot work in India not only justified the importance
and urgency, but also demonstrated the need to further
adapt and improve the pilot model to create a standardised
collaborative platform for both research and research capac-
ity building. This led to the establishment of the Maternal and
perinatal Health Research collaboration, India (MaatHRI), a
larger standardised collaborative research platform of 14 pub-
lic and private hospitals across four states in India. The objec-
tive of this paper is to describe the methods used to establish and
standardise the platform and the results of the process. MaatHRI
means mother in Sanskrit.
Methods
MaatHRI is a hospital-based collaborative research platform
established to: (i) regularly collect data on the prevalence of
known and emerging life-threatening pregnancy complica-
tions; (ii) conduct large epidemiological studies to generate evi-
dence to improve maternal and perinatal health in India; and
(iii) develop research capacity and skills in the collaborat-
ing hospitals. It was built on the pilot system, but extensively
expanded and standardised over a period of 18 months from
May 2017 to September 2018. The following methods were used
to establish the collaborative platform:
1. Establishing a network of hospitals and clinical
collaborators
2. Setting up a high-quality secure system for data collection,
storage, and transfer
3. Developing a standardised laboratory infrastructure
4. Implementing regulatory systems
Establishing a network of hospitals and clinical
collaborators
Successful completion of the pilot work in two hospitals in
Assam allowed us to expand the network from two to nine
government hospitals within Assam: six teaching hospi-
tals and four district hospitals. In each hospital, we identified
a lead collaborator who were obstetricians. Through their
professional networks, we were able to reach out to other
hospitals. A hospital was included in the network based on two
criteria: (i) willingness of the hospital to participate in a large
research collaboration and (ii) a high burden of maternal
and perinatal deaths in the population covered by the hospital.
Similar to the process used in the pilot work6, we mapped the hos-
pitals to assess the spread and coverage of the population in each
state.
Setting up a high-quality secure system for data collection,
storage and transfer
One of the major reasons for success of the pilot work was hav-
ing dedicated research staff for data collection and data entry.
A pragmatic approach was adopted to develop a high qual-
ity secure electronic system to overcome the challenges of
human resource constraints, lack of dedicated secure computer
servers for data storage in the hospitals, and securely sharing
data. The following methods were employed:
i. Research nurses were appointed in each hospital and
trained
ii. Electronic online data collection forms were developed
for entering data
iii. Data are collated automatically in a cloud-based server
located in India
iv. Quality assurance and data security procedures were
established and implemented
Standardised laboratory infrastructure
A laboratory infrastructure was created through a partner-
ship with a private laboratory in India, Dr Lal PathLabs (LPL).
LPL has a pan-India presence with a network of sample col-
lection centres, regional laboratories and a national reference
laboratory in New Delhi, India. Their existing service delivery
model was adapted to the requirements of the MaatHRI platform
through extensive consultations between the Indian clinical col-
laborators, and experts at the University of Oxford and LPL. The
following services were agreed and are being currently used to
standardise the laboratory infrastructure:
- Service 1: Provide blood collection kits with instructions
to all study hospitals
Page 4 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
- Service 2: Train MaatHRI research nurses to collect and
prepare blood samples
- Service 3: Transport samples at ambient conditions from
the hospitals to the laboratory
- Service 4: Standardise blood assays
- Service 5: Produce standardised test reports
We tested the model in a run-in phase before full
implementation.
Regulatory systems
The steering committee constituted for the pilot work (IndOSS-
Assam) was expanded to form the MaatHRI steering com-
mittee. The committee includes representatives from all the
collaborating hospitals, the University of Oxford, Indian pol-
icy advocates and experts in statistics and ethics. As MaatHRI
is a research platform set up to conduct studies on a long-
term basis, an independent ‘Data safety and monitoring board’
(DSMB) was set up, including members from India and the
UK who are not associated with the MaatHRI platform. A
DSMB charter was drafted outlining the roles and responsibili-
ties of the members and how the board will function to provide
independent safety review of participants and data, and guid-
ance for observational studies during the course of the ongo-
ing projects. Since the studies currently undertaken through
the platform are observational studies, review of adverse event
data and reports of serious adverse events (SAEs) are not
currently applicable to MaatHRI DSMB. However, should
randomised controlled trials be conducted through MaatHRI
in the future we would expect the DSMB to be involved in
reviewing this type of information.
Ethics approvals
The MaatHRI platform and the ongoing studies have been
approved by the institutional review boards (IRB) of each
coordinating Indian institution, namely: Srimanta Sankara-
deva University of Health Sciences, Guwahati, Assam (No.
MC/190/2007/Pt-1/126); Nazareth hospital, Shillong, Meghalaya
(Ref No. NH/CMO/IEC/COMMUNICATIONS/18-01); Emmanuel
Hospital Association, New Delhi (Ref. Protocol No.167);
Mahatma Gandhi Institute of Medical Sciences, Sevagram,
Maharashtra (Ref No. MGIMS/IEC/OBGY/118/2017); and
the Institute of Medical Sciences, Banaras Hindu University,
Varanasi, Uttar Pradesh (No.Dean/2018/EC/290). The project
has also been approved by the Government of India’s Health
Ministry’s Screening Committee, the Indian Council of Medical
Research, New Delhi (ID number 2018-0152) and by the
Oxford Tropical Research Ethics Committee (OxTREC),
University of Oxford, UK (OxTREC Ref: 7-18).
Results
MaatHRI network of hospitals
We were able to establish a network of 14 hospitals by
September 2018 across four states in India – Assam, Meghalaya,
Uttar Pradesh, and Maharashtra. After establishing the network,
two more hospitals joined MaatHRI, but two government dis-
trict hospitals left the collaboration. A lack of interest in
research and high patient load were the main reasons given by
the lead collaborators of the departing hospitals. The MaatHRI
platform currently includes a network of 14 hospitals (11 Gov-
ernment and 3 private). Figure 1 shows the distribution of the
Figure 1. Distribution of the MaatHRI collaborating hospitals and regions covered by the hospitals across India.
Page 5 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
network across India and within the state of Assam. The 14 hos-
pitals together conduct about 100,000 deliveries per year. The
network includes an Indian research team of 20 nurses, a project
manager, 16 obstetricians, two pathologists, a public health
specialist, a general physician and a paediatrician.
Setting up a high-quality and secure system for data
collection and storage
Data and biological sample collection: Depending on the
patient load and related participant recruitment rates, one or
two research nurses have been appointed in each collaborat-
ing hospital for the MaatHRI work. The nurses are responsible
for recruiting study participants, providing participant informa-
tion and obtaining informed consent, collecting data and blood
samples, and following up participants. The research nurses were
specifically trained to undertake these activities. In addition,
a project manager has been appointed to manage the research
nurses and provide supportive supervision.
Data entry and storage: Our original plan was for research
nurses to collect data in online electronic forms using tablet PCs
enabling automatic collation in the Microsoft Azure cloud com-
puting platform (Microsoft Corporation) with servers located
in India; there is no provision for storing data on the tablets.
However, after an initial trial we found that direct data entry in an
online form was not possible due to problems with internet con-
nections in several hospitals and the sensitivity associated with
a nurse standing with a tablet PC next to a very sick woman. It
was therefore decided that paper forms would be used to collect
data in these hospitals and the nurse would enter the data imme-
diately afterwards into the online data portal and then destroy
the paper forms. Each hospital has a unique Login ID and
password to access the data collection forms and their collated
data on the online portal.
Quality assurance and data security: The electronic data col-
lection forms have checks and validations to flag logical errors.
The project manager is responsible for monitoring data entry
on a day-to-day basis. Red flags are raised for errors and
incomplete forms immediately so that the research nurse can
rectify the errors before the participant is discharged from the
hospital. Data stored in the cloud server are encrypted and
password protected. Each collaborating hospital can only view
and download its own data. Identifiable information are collected
for follow-up of participants, but these can only be viewed by the
authorised hospital staff and cannot be downloaded by anyone.
Once the data collection is complete, in preparation for analy-
sis, all identifiable information is completely delinked from
the clinical data to generate pseudonymised analysis files. We
have developed secure mechanisms for transferring data within
India and between India and the UK with recommended level of
end-end-encryption.
Laboratory infrastructure
Dr Lal Pathlabs (LPL) provides the laboratory infrastructure
for MaatHRI. The following services were tested in a trial
run before being fully incorporated into the platform.
Service 1: Blood collection kits with instructions to all study
hospitals. LPL provides the required blood collection kits with
specific written guidance to all study hospitals for collecting,
processing and packing the blood samples.
Service 2: Train MaatHRI research nurses to collect and
prepare blood samples. Technical experts from the labora-
tory trained the MaatHRI staff (project manager and research
nurses) to collect, centrifuge and pack samples before the start
of studies. When required, a phlebotomist from their collec-
tion centre provided supportive supervision to the research
nurses during the initial few weeks to correct or prevent any
errors.
The MaatHRI research nurses collect, centrifuge and pack blood
samples as per instructions in transportation boxes ready for
collection by LPL. A standard test requisition form for each
participant is filled in by the obstetrician caring for the par-
ticipant. This form only includes the participant ID, age and
a barcode to ensure participant confidentiality and blind-
ing to minimise reporting bias. The test results are only used
for research purposes and not for the provision of clinical
care.
Service 3: Transport samples at ambient conditions from the
hospitals to the laboratory. A designated person from the LPL
collection centre collects the boxes from the hospital. These
are transported via road to the nearest regional laboratory where
they are checked and then shipped via air to the national labo-
ratory in New Delhi. A flow-chart describing the transporta-
tion process from the hospitals to the LPL National Reference
Laboratory is shown in Figure 2 and the network is presented
in a map in Figure 3. Time in transit is regularly monitored
by LPL and reported for each participant along with their test
results.
Service 4: Standardising blood assays. All samples are proc-
essed and analysed in the LPL National Reference Labora-
tory based at New Delhi. The assay methods, traceability and
performance characteristics are discussed by experts from the
University of Oxford’s Wolfson laboratory and LPL before
including a test in the study. Table 1 shows the traceability and
Table 2 shows the performance characteristics for assays that
are commonly used for the epidemiological studies undertaken
using the MaatHRI platform. The details of specific tests will
be presented in subsequent publications. Traceability and assay
performance monitoring are important for standardisation of
laboratory procedures and quality control. If the quality of
a blood sample is compromised in transit, it is not proc-
essed, and the site-collaborator and research nurse are advised
to collect a fresh sample. The laboratory runs quality con-
trol checks daily for each assay (twice a day for some) and
monitors their mean coefficient of variation and standard devia-
tion. The results are shared as part of a performance moni-
toring plan during monitoring and feedback meetings. In
addition, LPL also runs a quarterly Quality Improvement
Programme.
Page 6 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
Figure 2. A flow-chart showing the transportation of samples from the hospital to the Dr Lal PathLabs National Reference Laboratory
for processing and analysis.
Page 7 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
Table 1. Traceability of assays.
Sl No Name of test Calibrator traceability (reference
material/ reference method) Units
Typical
calibrator
value
Calibrator uncertainty of
measurement
1 Haemoglobin
1:250 dilution in NCCLS2 recommended
reagent for the hemiglobincyanide
cyanmethemoglobin
g/dl 12.58 1.00%
2 Hematocrit Calculated % Calculated NA
3 Platelets
A 1:101 dilution is made using a 20
μL TC pipette and 2 mL of 1% filtered
ammonium oxalate (CLSI/ formerly
NCCLS)
thou/mm3 214.1 6.00%
4 Serum Ferritin WHO 3rd International Standard 94/572 ng/ml Low 5.44
High 953
Low 19.5
High 9.3
5Haemoglobin
electrophoresis NGSP Certification for A2/F % HbF-6.6 % and
HbA2-6.7 %
HbF- Low- NA, High 1.8 %
HbA2- Low-NA, High- 3.6 %
NGSP - National Glycohemoglobin Standardization Program; CLSI – Clinical and Laboratory Standards Institute; HbF – Fetal haemoglobin; HbA2
- Haemoglobin Subunit Alpha 2; NA - Not applicable
Figure 3. Laboratory network for the MaatHRI platform.
The LPL National Reference Laboratory is accredited by the
following bodies – College of American Pathologists (CAP);
National Accreditation Board for Testing and Calibration (NABL);
British Standards Institution (Quality Management System
ISO 9001: 2015, FS 60411).
Service – 5: Test reports. Test reports are securely made avail-
able to the site-collaborator in each hospital through their usual
communication channel. Data from the reports are entered
in the electronic forms by the research nurse.
Regulatory systems
MaatHRI steering committee has met biannually since the plat-
form was established in September 2018. The role of the steer-
ing committee is to guide the platform in terms of vision, scope,
equitable partnership, and research and training priorities.
Page 8 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
Table 2. Assay Information and performance characteristics.
Name of test System used for
the analysis
Method information
(supplier/ method)
Manufacturers’
analytical range
Laboratory
reportable
range
Normal reference
range (adult
woman not
pregnant)
Biological
variation
Uncertainty of
measurement
Quality
control
material
External
quality
assurance
Haemoglobin DxH -800
(Beckman coulter) Photometric 0.1-25.5 1-25 11.50-15 g/dl 2.5 4.9
Coulter
6c cell
control
CAP
Hematocrit DxH -800
(Beckman coulter)
Automated
calculation Not applicable Not applicable 36-46% 1.6 3.1
Coulter
6c cell
control
CAP
Platelets DxH -800
(Beckman coulter)
Impedance/coulter
principle 3-3000 10-1000 150-450 thou/
mm3 2.6 5.2
Coulter
6c cell
control
CAP
Serum Ferritin Siemens ADVIA
Centaur
Chemiluminescence
Immunoassay (CLIA) 0.5 – 1650 ng/ml <0.5,
>16500 10-291ng/ml 14.2 22.5 BIO-RAD CAP PT
Haemoglobin
electrophoresis
Variant II
Hemoglobin
testing system
(BIO-RAD)
High Performance
Liquid
Chromatography
HbF-1.3-44.3 %
HbA2-1.6-18.7 %
HbF-1.3-99.8%
HbA2-1.6-18.7 %
HbF- <1.5 %
HbA2-1.5-3.5 %
HbF-6.8 %
HbA2-4.5 %
HbF-13.2 %
HbA2-8.8 % BIO-RAD CAP
CAP - College of American Pathologists; CAP PT - College of American Pathologists Proficiency Testing programme; HbF – Fetal haemoglobin; HbA2 - Haemoglobin Subunit Alpha
Page 9 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
It is also responsible for communicating the results of the
studies undertaken through MaatHRI to the Ministry of Health
and Family Welfare (MoHFW), Government of India.
The DSMB periodically reviews participant recruitment, data
safety and confidentiality, ethical issues and data quality, and
examines whether the overall safety and feasibility of the
MaatHRI project is acceptable. Although conventionally DSMB
is set up for individual studies, we found that setting up a DSMB
for the research platform that has oversight of all studies
undertaken through the platform could be an effective way to
ensure data safety. The DSMB has met twice since MaatHRI was
established in September 2018 and membership includes two
obstetricians (one from the UK and one from India), one paedi-
atrician (from India), one biostatistician (from the UK), and one
expert in bioethics (from India), all with prior experience and
expertise in observational epidemiological studies. They were
nominated by the study investigators.
Studies currently being undertaken through the MaatHRI
platform
One survey and three observation studies are currently being
undertaken through the platform. A monthly survey of nine life-
threatening complications of pregnancy has been in progress
since July 2018. The complications are defined using standard
definitions and include eclampsia, pre-eclampsia, postpartum
haemorrhage, maternal peripartum infection, septic abortion,
uterine rupture, heart failure during pregnancy and postpar-
tum, transient peripheral neuropathy, and Japanese encephalitis
complications.
The epidemiological studies undertaken are informed by the
knowledge and hypothesis generated during the pilot work for
IndOSS-Assam. They include: (i) an unmatched case-control
study examining the risk factors, clinical characteristics, and
outcomes of heart failure in pregnant and postpartum women;
(ii) a prospective cohort study investigating the safety of induc-
tion and augmentation of labour in pregnant women with
anaemia; and (iii) a nested study within the prospective study
comparing the coagulation parameters in pregnant women with
and without anaemia. Of these, the nested coagulation study
is complete, and the other two studies will be completed by
June 2022. The monthly survey will continue as long as the
collaborative platform exists.
Discussion
MaatHRI, a collaborative research platform, modelled on
UKOSS, was successfully established to conduct hospital-based
research to improve care and outcomes for mothers and babies
in India. It includes 14 public and private hospitals across four
states in India, which together conduct about 100,000 deliv-
eries per year. The platform is standardised in terms of data
collection, equipment, and laboratory methodology, and
employs strict measures for participant confidentiality and
data security. It is monitored by two regulatory bodies: a steer-
ing committee and an independent DSMB. One survey and
three epidemiological studies are being undertaken through the
platform.
MaatHRI is the first prototype of UKOSS and other similar
platforms9 in a low and middle income country (LMIC). Within
this setting, it covers the most deprived and vulnerable popula-
tion groups. The MaatHRI platform, although built on models
of existing surveillance and research platforms in high income
countries, is more advanced in terms of using current best
practices for standardisation of data and laboratory parameters,
monitoring data and participant safety, and secure transfer of
data within and between countries. All biological samples are
analysed at the LPL National Reference Laboratory. The pre-
cision, performance and quality of each laboratory parameter
are documented and maintained to a high level. The laboratory
partnership also benefits from subsidised costs from LPL for
each test, at a rate that is 40% less than their commercial price,
with no additional costs for transportation and project manage-
ment. The laboratory has also started tests for the MaatHRI
project, which they did not offer previously. This involved com-
pleting extensive validation processes. In addition to high quality
and standardisation of the laboratory procedures, the pseudo-
nymised laboratory model ensures confidentiality of participants
and minimises reporting bias.
Another advantage of the MaatHRI platform is the ability to
undertake long term follow-up studies of participants. Identifi-
able information collected locally from participants helps to
locate each participant by hospital staff for follow-up. All stud-
ies currently undertaken through the platform have a follow-up
component with the potential to generate participant cohorts,
based on informed consent, for long term follow-up of the
effects of pregnancy complications. Adequate measures have
been put in place for securely storing the identifiable informa-
tion and destroying it after the cohorts for long term follow-up
have been established. An independent MaatHRI DSMB
monitors data safety and participant confidentiality on an
ongoing basis, thereby ensuring confidence and trust on the
research platform.
While the platform is established and is currently running
three epidemiological studies, the process to develop capac-
ity for research and further improving pregnancy care will con-
tinue and is an integral part of the MaatHRI collaboration.
The focus is on bi-directional skills development and capacity
building through mutual learning between the collaborators in
India and the UK. The platform is also being used to develop
the research capacity of early career researchers (MSc and
PhD students and post-doctoral researchers) interested in
working in maternal and perinatal health in an LMIC setting.
Strengths and challenges
MaatHRI is a collaboration of hospitals that covers deprived
populations, some of which are located in remote rural areas of
India. While this provides the opportunity to conduct research
to improve the health of mothers and babies in areas of the
Page 10 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
country that have the highest burden of maternal and perinatal
deaths, it also poses challenges related to resources and capac-
ity. Appointing new research nurses to collect data and blood
samples ensured that the MaatHRI platform was not depriving
the hospitals of their scarce human resource. This has created
an employment opportunity for nurses in the field of research,
which is not a usual job for trained nurses in India. However,
the challenge associated with this was the need for exten-
sive training and constant supervision of the nurses. Further-
more, most of the collaborating hospitals had not been involved
in a project of this scale and intensity encompassing not
just implementation, but designing, standardising and develop-
ing the project as equal partners. Therefore, it took more than
20 months of continuous engagement with staff and collabora-
tors to achieve the desired level of quality and standardisation
for the MaatHRI platform.
Within the resource constraints, a further challenge is achiev-
ing a balance between an ideal collaborative research
platform and a pragmatic solution. For example, the ideal
platform would have collected data electronically on tablets
using online forms, but this was not feasible due to a lack of
good internet connectivity in the remote hospitals and cultural
sensitivities. Therefore, paper forms are used in some hospi-
tals. However, to mitigate risks and as advised by the DSMB,
we have developed a documented process of securely storing
and destroying the paper forms within an agreed timeline for
each hospital.
Costs related to research staff, standardised laboratory param-
eters, programming data collection forms, and storing data
on Microsoft Azure make studies undertaken through the
MaatHRI platform more expensive compared with existing simi-
lar systems in the UK8, Europe and Australia9. It is our belief,
however, that the benefits of generating high quality scientific
evidence to answer important and urgent clinical research ques-
tions that will save the lives of thousands of future mothers
and babies, outweigh these additional costs.
Conclusion
In summary, the methods that we have used to develop the
MaatHRI platform make it a unique and high-quality research
resource using a model that can be replicated in other LMICs.
Since being established in September 2018, MaatHRI has already
secured further funding, including industry funding. One epi-
demiological study is complete and two others are in various
stages of participant recruitment and data collection. We intend
to make the data generated through the MaatHRI platform
available to researchers for secondary analysis. In addi-
tion to research impact, our approach to building the plat-
form on the premise of equitable partnership between all
collaborators and developing research capacity in the collabo-
rating institutions will further contribute to the sustainability of
MaatHRI.
Data availability
No data is associated with this article.
Acknowledgments
We thank Prof. U C Sarma, retired Vice Chancellor of Srimanta
Sankaradeva University of Health Sciences, Guwahati, Assam
for his valuable contribution in establishing the MaatHRI
platform. We also thank Prof. Hem Kanta Sarma, Professor
and Head of the Department of Obstetrics and Gynaecology,
Jorhat Medical College and Hospital, Assam for his contribution
during the initial phase of setting up MaatHRI.
A previous version of this study is available as a preprint on
Authorea, https://doi.org/10.22541/au.158931017.74200443
References
1. World Health Organization: The World health report : 2005 : make every mother
and child count. Geneva: World Health Organization, 2005.
Reference Source
2. Graham W, Woodd S, Byass P, et al.: Diversity and divergence: the dynamic
burden of poor maternal health. Lancet. 2016; 388(10056): 2164–2175.
PubMed Abstract
|
Publisher Full Text
3. WHO, UNICEF, UNFPA,, et al.: Maternal mortality: Levels and trends 2000 to
2017. Geneva: World Health Organisation, 2019.
Reference Source
4. Office of Registrar General and Census Commissioner India: Annual Health
Survey 2012-13: Fact sheet. New Delhi: Ministry of Home Affairs, Government of
India, 2014.
5. Knight M, Bunch K, Tuffnell D, et al.: Saving Lives, Improving Mothers’ Care -
Lessons learned to inform maternity care from the UK and Ireland Confidential
Enquiries into Maternal Deaths and Morbidity 2015-17. Oxford: National
Perinatal Epidemiology Unit, University of Oxford, 2019.
Reference Source
6. Nair M, Choudhury MK, Choudhury SS, et al.: IndOSS-Assam: Investigating
the feasibility of introducing a simple maternal morbidity surveillance and
research system in Assam, India. BMJ Glob Health. 2016; 1(1):
e000024.
PubMed Abstract
|
Publisher Full Text
|
Free Full Text
7. Nair M, Choudhury MK, Choudhury SS, et al.: The association between maternal
anaemia and pregnancy outcomes: a cohort study in Assam, India. BMJ Glob
Health. 2016; 1: e000026.
PubMed Abstract
|
Publisher Full Text
|
Free Full Text
8. Knight M, Lindquist A: The UK Obstetric Surveillance System: Impact on patient
safety. Best Pract Res Clin Obstet Gynaecol. 2013; 27(4): 621–30.
PubMed Abstract
|
Publisher Full Text
9. Knight M, INOSS: The International Network of Obstetric Survey Systems
(INOSS): benefits of multi-country studies of severe and uncommon maternal
morbidities. Acta Obstet Gynecol Scand. 2014; 93(2): 127–31.
PubMed Abstract
|
Publisher Full Text
Page 11 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020
The benefits of publishing with F1000Research:
Your article is published within days, with no editorial bias
You can publish traditional articles, null/negative results, case reports, data notes and more
The peer review process is transparent and collaborative
Your article is indexed in PubMed after passing peer review
Dedicated customer support at every stage
For pre-submission enquiries, contact research@f1000.com
Page 12 of 12
F1000Research 2020, 9:683 Last updated: 07 JUL 2020